Q2 2025 Holdings
Filed 2025-08-14 | 93 holdings | $1.6B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $96.9M | 175,750 | 6.0% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $90.8M | 116,500 | 5.7% |
| Merus N V | COM | N5749R100 | $55.9M | 1,063,608 | 3.5% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $54.4M | 861,153 | 3.4% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $52.8M | 525,000 | 3.3% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $50.6M | 1,391,072 | 3.2% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $49.0M | 1,330,960 | 3.1% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $44.6M | 82,000 | 2.8% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $42.5M | 140,296 | 2.6% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $41.6M | 818,206 | 2.6% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $38.1M | 355,000 | 2.4% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $37.5M | 217,000 | 2.3% |
| Irhythm Technologies Inc(IRTC) | COM | 450056106 | $37.3M | 242,500 | 2.3% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $34.2M | 640,526 | 2.1% |
| Penumbra Inc(PEN) | COM | 70975L107 | $33.0M | 128,500 | 2.1% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $32.9M | 989,745 | 2.1% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $32.6M | 100,000 | 2.0% |
| Evolent Health Inc(EVH) | CL A | 30050B101 | $31.8M | 2,820,700 | 2.0% |
| ZAI LAB LTD(ZLAB) | ADR | 98887Q104 | $30.5M | 871,392 | 1.9% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $30.4M | 572,000 | 1.9% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $29.2M | 931,681 | 1.8% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $28.2M | 1,908,208 | 1.8% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $28.1M | 794,133 | 1.8% |
| Dexcom Inc(DXCM) | COM | 252131107 | $25.0M | 286,750 | 1.6% |
| Phreesia Inc(PHR) | COM | 71944F106 | $23.8M | 837,300 | 1.5% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $23.8M | 185,500 | 1.5% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $23.6M | 1,135,879 | 1.5% |
| Tenet Healthcare Corp(THC) | COM NEW | 88033G407 | $22.9M | 130,000 | 1.4% |
| Caris Life Sciences Inc(CAI) | COM | 142152107 | $21.2M | 793,651 | 1.3% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $19.7M | 450,374 | 1.2% |
| Omada Health Inc(OMDA) | COM | 68170A108 | $16.8M | 919,951 | 1.0% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $16.5M | 812,653 | 1.0% |
| Azenta Inc(AZTA) | COM | 114340102 | $16.3M | 530,400 | 1.0% |
| Acadia Healthcare Company in(ACHC) | COM | 00404A109 | $15.8M | 696,000 | 1.0% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $15.8M | 50,500 | 1.0% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $15.1M | 373,750 | 0.9% |
| Summit Therapeutics Inc(SMMT) | COM | 86627T108 | $15.1M | 710,000 | 0.9% |
| Agilon Health Inc(AGL) | COM | 00857U107 | $15.1M | 6,550,400 | 0.9% |
| Oscar Health Inc(OSCR) | CL A | 687793109 | $15.0M | 700,000 | 0.9% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $14.5M | 617,396 | 0.9% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $14.1M | 701,408 | 0.9% |
| Inspire MED SYS Inc(INSP) | COM | 457730109 | $14.0M | 107,500 | 0.9% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $12.9M | 154,528 | 0.8% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $12.9M | 4,962,955 | 0.8% |
| Spdr Series Trust(XBI) | S&P BIOTECH | 78464A870 | $12.6M | 151,750 | 0.8% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $12.3M | 186,314 | 0.8% |
| Mereo Biopharma Group PLC(MREO) | SPON ADS | 589492107 | $12.1M | 4,465,292 | 0.8% |
| Danaher Corporation(DHR) | COM | 235851102 | $11.7M | 59,000 | 0.7% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $11.2M | 1,960,334 | 0.7% |
| West Pharmaceutical Svsc Inc(WST) | COM | 955306105 | $11.2M | 51,030 | 0.7% |